Antitumor Efficacy of SLPI Promoter-Controlled Expression of Artificial microRNA Targeting EGFR in a Squamous Cell Carcinoma Cell Line
- 18 January 2017
- journal article
- research article
- Published by Springer Nature in Pathology and Oncology Research
- Vol. 23 (4) , 829-835
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Epidermal growth factor receptor (EGFR) and squamous cell carcinoma of the skin: Molecular bases for EGFR-targeted therapyPathology - Research and Practice, 2011
- Understanding resistance to EGFR inhibitors—impact on future treatment strategiesNature Reviews Clinical Oncology, 2010
- Epidermal growth factor receptor targeted therapy of squamous cell carcinoma of the head and neckHead & Neck, 2010
- Reexamining the treatment of advanced laryngeal cancerHead & Neck, 2009
- Platinum-Based Chemotherapy plus Cetuximab in Head and Neck CancerNew England Journal of Medicine, 2008
- Modeling oncogene addiction using RNA interferenceProceedings of the National Academy of Sciences, 2008
- Secretory leukocyte peptidase inhibitor and lung cancerCancer Science, 2008
- Epidermal growth factor receptor (EGFR) signaling in cancerGene, 2006
- ERBB receptors and cancer: the complexity of targeted inhibitorsNature Reviews Cancer, 2005
- Cutaneous Squamous-Cell CarcinomaNew England Journal of Medicine, 2001